Two former Qualcomm Inc. managers were criminally charged with insider trading for allegedly buying shares of a semiconductor maker before Qualcomm announced an agreement to buy the company.
Botox maker Allergan is rejecting a takeover bid from Valeant Pharmaceuticals, saying that the unsolicited $46 billion offer undervalues the company and carries significant risk.
Chrysler Group lost $690 million in the first quarter due to charges related to its merger with Italian automaker Fiat SpA.
Hillshire Brands is buying Pinnacle Foods, whose brands include Duncan Hines and Aunt Jemima, in a cash-and-stock deal valued at approximately $4.23 billion.
Apple is orchestrating a $3.2 billion acquisition of Beats Electronics, the headphone maker and music streaming distributor founded by hip-hop star Dr. Dre and record producer Jimmy Iovine, according to a published report.
The deal is part of a $3.5 billion restructuring program underway at Mondelez that is projected to create $1.5 billion in savings by 2018.
The pretzel and chip maker is selling its private brands and two manufacturing plants to Shearer's Foods LLC for $430 million as it hones its focus on its well-known brands.
French President Francois Hollande says that an offer by General Electric Co. for troubled French engineering company Alstom is not good enough and wants the U.S. company to come up with a better deal.
Bayer has agreed to buy Merck & Co.'s non-prescription medicine and consumer care business for $14.2 billion, gaining products such as Claritin allergy pills, Coppertone sun lotion and Dr. Scholl's footcare products.
Executives at drug maker Pfizer Inc. say they're continuing to review options after British rival AstraZeneca PLC again rejected their proposal to buy the company, adding that Pfizer would prefer a friendly deal.
That is one of the strategic options the company said over the weekend that it was considering, as well as merging with another company or spinning off one of its businesses.
The board of pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer's sweetened takeover offer just hours after it was levelled, describing it as inadequate.
French engineering company Alstom has received a purchase offer from Germany's Siemens, putting another party at the bargaining table with General Electric Co.
In the first quarter of 2014, the total value for merger and acquisition (M&A) activity in the industrial manufacturing sector surpassed both the previous quarter and the same time period in 2013, largely driven by the successful completion of several mega deals, or transactions worth more than $1 billion.
Pfizer Inc. was turned down twice by fellow drug maker AstraZeneca PLC, but the maker of Viagra and Lipitor said Monday that its proposed $100 billion acquisition makes sense for shareholders of both companies.
French President Francois Hollande met with top members of the government to discuss Alstom, hours after the economy minister warned the engineering company not to pursue a "precipitous" tie-up with General Electric.
Forest Laboratories says it will spend as much as $1.5 million to buy Furiex Pharmaceuticals Inc. in a deal that could give the drug maker one of the broadest product lines for gastrointestinal treatments.
A German court has thrown out market manipulation charges against the former CEO and chief financial officer of Porsche over the sports car maker's failed attempt to take over Volkswagen AG in 2009.
Friday's closure of the deal, which includes a license to a portfolio of Nokia patents, follows delays in global regulatory approvals, including from China.
Shares in French train and equipment manufacturer Alstom have spiked on reports that General Electric Co. is considering making a bid for the company.
Volkswagen has come closer to realizing its ambition to takeover Scania after the fourth largest shareholder in the Swedish truck maker announced it will accept the $9.2 billion bid.
Just over a month after buying Beechcraft for $1.4 billion, Textron announced 750 job cuts at that company and at its Cessna division.
Swiss pharmaceutical giant Novartis announced a series of multibillion-dollar deals with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.
Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45 billion.